Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol Before Elective Caesarean Section for Decreasing the Neonatal Respiratory Morbidity
NCT03031353Unknown
- Sponsor
- Ain Shams University
- Start
- Jan 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in neonatal respiratory distress syndrome (NRDS) and transient tachypnea of the newborn (TTN) comparing Misoprostol with Placebo (2 arms). Primary endpoint: Need for admission to neonatal intensive care unit (NICU) at 24 hours. Status: unknown.
02
Drugs
misoprostol
03
Conditions
neonatal respiratory distress syndrome (NRDS)transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on NCT03031353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03031353.